Sources | Names Used |
---|---|
CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AATK-AS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ABAT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ABCA5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC002310.11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | AC002310.13 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |